First Header Logo Second Header Logo

Connection

Roy Hantgan to Thrombolytic Therapy

This is a "connection" page, showing publications Roy Hantgan has written about Thrombolytic Therapy.
Connection Strength

0.040
  1. Handt S, Jerome WG, Tietze L, Hantgan RR. Plasminogen activator inhibitor-1 secretion of endothelial cells increases fibrinolytic resistance of an in vitro fibrin clot: evidence for a key role of endothelial cells in thrombolytic resistance. Blood. 1996 May 15; 87(10):4204-13.
    View in: PubMed
    Score: 0.030
  2. Huang TC, Jordan RE, Hantgan RR, Alevriadou BR. Differential effects of c7E3 Fab on thrombus formation and rt-PA-Mediated thrombolysis under flow conditions. Thromb Res. 2001 Jun 01; 102(5):411-25.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.